- Research works
- 105 ▼ 19% vs 2013–17
- Citations
- 3.1k 29.2 per fractional work
- Top-10% rate
- 17.7% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: Ontario Clinical Oncology Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.6×. Every wedge is a field page.
- Medicine 3.6×
- Dentistry 2.0×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Immunology and Microbiology 1.4×
- Nursing 1.0×
- Health Professions 0.9×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Mathematics 0.8×
- Materials Science 0.6×
- Agricultural and Biological Sciences 0.4×
- Engineering 0.4×
- Psychology 0.3×
- Decision Sciences 0.3×
- Physics and Astronomy 0.3×
- Economics, Econometrics and Finance 0.3×
- Social Sciences 0.2×
- Chemistry 0.2×
- Environmental Science 0.2×
- Neuroscience 0.1×
Which keywords describe research at Ontario Clinical Oncology Group?
By fractional works in all years, weighted toward what it does more of than the world: Clinical Practice Guidelines, Chemotherapy, Treatment, Diagnosis, Clinical Trials, Immunotherapy, Radiotherapy and Risk Factors.
- Treatment Response
- Hepatocellular Carcinoma
- Taxanes
- Radiation Therapy
- Cancer Survivorship
- Prognostic Markers
- Molecular Subtypes
- Venous Thromboembolism
- Prognostic Factors
- Targeted Therapy
- Survival Analysis
- Antithrombotic Therapy
- Prophylaxis
- Neoadjuvant Therapy
- Management
- Radiotherapy
- Clinical Trials
- Quality of Life
- Chemotherapy
- Epidemiology
- Clinical Practice Guidelines
- Treatment
- Diagnosis
- Risk Factors
- Immunotherapy
- Inflammation
- Biomarkers
- Cancer
- Prostate Cancer
- Immune Response
- Genomic Profiling
- Genetic Mutations
- Pulmonary Embolism
- Guidelines
- Metastatic Breast Cancer
- Breast Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Survival
- Breast Tumours
- Hormone Therapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Clinical Practice Guidelines9▲ 15×11 topics
- Epidemiology8▲ 1.97×36 topics
- Treatment7▲ 5.2×15 topics
- Chemotherapy7▲ 8.9×18 topics
- Diagnosis7▲ 6.2×13 topics
- Quality of Life6▲ 4.3×20 topics
- Risk Factors6▲ 5.2×14 topics
- Clinical Trials6▲ 8.4×13 topics
- Immunotherapy5▲ 8.0×15 topics
- Radiotherapy5▲ 13×10 topics
- Inflammation5▲ 1.88×24 topics
- Management4▲ 5.5×16 topics
- Biomarkers4▲ 6.5×11 topics
- Neoadjuvant Therapy4▲ 17×5 topics
- Cancer4▲ 2.5×19 topics
- Prophylaxis4▲ 25×3 topics
- Prostate Cancer4▲ 22×4 topics
- Antithrombotic Therapy3▲ 30×2 topics
- Immune Response3▲ 5.0×7 topics
- Survival Analysis3▲ 12×6 topics
- Genomic Profiling3▲ 30×2 topics
- Targeted Therapy3▲ 14×5 topics
- Genetic Mutations3▲ 5.5×9 topics
- Prognostic Factors3▲ 6.2×12 topics
- Pulmonary Embolism3▲ 41×1 topic
- Venous Thromboembolism3▲ 41×1 topic
- Guidelines3▲ 5.7×11 topics
- Molecular Subtypes3▲ 30×2 topics
- Metastatic Breast Cancer3▲ 38×2 topics
- Prognostic Markers2▲ 24×3 topics
- Breast Cancer2▲ 7.8×10 topics
- Cancer Survivorship2▲ 34×2 topics
- Chemotherapy-Induced Peripheral Neuropathy2▲ 40×1 topic
- Radiation Therapy2▲ 14×4 topics
- Survival2▲ 15×3 topics
- Taxanes2▲ 40×1 topic
- Breast Tumours2▲ 39×1 topic
- Hepatocellular Carcinoma2▲ 8.9×3 topics
- Hormone Therapy2▲ 18×2 topics
- Treatment Response2▲ 39×1 topic
Which research topics does Ontario Clinical Oncology Group publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Palliative Care and End-of-Life Issues and Nutrition and Health in Aging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 2 Breast Cancer Treatment Studies Cancer Research 0 works
- 3 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works
- 4 Nutrition and Health in Aging Physiology 0 works
- 5 Metal Alloys Wear and Properties Materials Chemistry 0 works
- 6 Global Cancer Incidence and Screening Oncology 0 works
- 7 Hepatitis C virus research Hepatology 0 works
- 8 Head and Neck Cancer Studies Otorhinolaryngology 0 works
- 9 Hepatitis B Virus Studies Epidemiology 0 works
- 10 Cancer Diagnosis and Treatment Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ontario Clinical Oncology Group's research output changed?
Output in 2018–2022 was 19% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hamilton
- McMaster University
- McMaster University Medical Centre
- Hamilton Health Sciences
- St. Joseph’s Healthcare Hamilton
- Population Health Research Institute
- McMaster Children's Hospital
- Juravinski Cancer Centre
- Hamilton General Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.